RE:RE:RE:RX is undervaluedI am estimating that they will accelerate their growth ... so 4 produts next year, 5 products the year after and 7 new products three years out... Also, as their sales force gets bigger they will appeal to more mass market style products, and with all their relationships, and proven expertise at bringing products to market I think they will start to land the odd 50 mill size product mixed in with their typical smaller size ones... My guess is they will be adding 100 million to sales per year three years out...
We are doing this at a very good time -- compared to Paladin as an example.. Firstly, many more drugs are coming off patent and generics are coming out -- this is a big opportunity... I especially like the specialty generics where the drug is the same but the delivery (or other feature) is improved... Secondly, technology is converging and growing exponentially and as a result there is a huge ramp in the quantity of new products coming out..many companies from Europe or USA will seriously look to companies like RX to off-load the Canadian market with their new products...